CAPITAL4 NEWS

 

  • NIFTY4,860.5  
  • -45.6 -0.9%
  • SENSEX16,026.4  
  • -156.9 -1.0%

Glenmark Generics receives two oral contraceptives product approvals

Source: Capital Market, Saturday, January 21st, 08:01 AM

Glenmark Generics Inc., USA, a subsidiary of Glenmark Generics has received final approval for two abbreviated new drug applications (ANDA) from United States Food and Drug Administration (USFDA). The company has received approval for oral contraceptive products Norethindrone and Ethinyl Estradiol (Alyacen 1/35) tablets USP, 1 mg/0.035 mg and Norethindrone and Ethinyl Estradiol (Alyacen 7/7/7) tablets USP, 0.75 mg/0.035 mg, 0.75 mg/0.035 mg and 1 mg/0.035 mg, the generic equivalents of Ortho-McNeil Janssen's Ortho-Novum 1/35-28 tablets and Ortho-Novum 7/7/7-28 tablets respectively.

TOP BLOGS

View all blogs